Goldman Sachs senior biotechnology analyst in global investment research Chris Shibutani joins Market Domination Hosts Julie ...

Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Super Micro stock surges, and ...

In a previous interview, Lee hinted that a period of market volatility is expected, as 2024 heads for a soft landing.

With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to be looking for bargains all the more intently. On average, the ...

AbbVie has been reporting an earnings decline because its former lead drug, Humira, lost patent-protected market exclusivity ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...

You can find plenty of affordable stocks that offer solid long-term growth prospects. If you're interested in the healthcare ...

Here are some of the major companies whose stocks moved on the week’s news.

We recently published a list of 7 Best Low Cost Stocks To Buy Under $50. In this article, we are going to take a look at ...

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday. Shares of Pfizer Inc PFE rose during ...